Osteoporosis, Postmenopausal Concept

subject area of

• 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.  Academic Article
• A Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis  Academic Article
• A Randomized Controlled Trial of Vitamin D Supplementation on Preventing Postmenopausal Bone Loss and Modifying Bone Metabolism Using Identical Twin Pairs  Academic Article
• A Randomized Controlled Trial to Compare the Efficacy of Cyclical Parathyroid HormoneVersusCyclical Parathyroid Hormone and Sequential Calcitonin to Improve Bone Mass in Postmenopausal Women with Osteoporosis¹  Academic Article
• A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis  Academic Article
• A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part II: 1-Yr Change, Long-Term Precision, and Least Significant Change  Academic Article
• A community-based clinical trial of Intra-Venous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: The IVORY trial  Academic Article
• A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis  Academic Article
• Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures  Academic Article
• Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database  Academic Article
• Advances in osteoporosis therapy. 2003 update of practical guidelines.  Academic Article
• Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study  Academic Article
• Age and drug therapy are key prognostic factors for first clinical fracture in patients with primary osteoporosis  Academic Article
• Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.  Academic Article
• Anabolic Agents: A New Chapter in the Management of Osteoporosis  Academic Article
• Ankle fractures do not predict osteoporotic fractures in women with or without diabetes  Academic Article
• Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture  Academic Article
• Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: An 18-month, multicenter, open-label, prospective study  Academic Article
• Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS)  Academic Article
• Association of larger holes in the trabecular bone at the distal radius in postmenopausal women with type 2 diabetes mellitus compared to controls  Academic Article
• Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis  Academic Article
• Bisphosphonate addition to stable hormone replacement therapy increases bone mineral density in postmenopausal women.  Academic Article
• Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada  Academic Article
• Bone Densitometry: Applications and Limitations  Academic Article
• Bone Marrow and Muscle Fat Infiltration Are Correlated among Postmenopausal Women With Osteoporosis: The AMBERS Cohort Study  Academic Article
• Bone fractures after menopause  Academic Article
• Bone turnover markers in the management of postmenopausal osteoporosis  Academic Article
• Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture  Academic Article
• Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women  Academic Article
• Calcium supplementation on bone loss in postmenopausal women  Academic Article
• Calcium supplementation on bone loss in postmenopausal women  Academic Article
• Calcium supplementation on bone loss in postmenopausal women  Academic Article
• Challenges for Model-Based Economic Evaluations of Postmenopausal Osteoporosis Interventions  Academic Article
• Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study  Academic Article
• Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis  Academic Article
• Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis.  Academic Article
• Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis  Academic Article
• Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis  Academic Article
• Comparison between Frailty Index of Deficit Accumulation and Phenotypic Model to Predict Risk of Falls: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton Cohort  Academic Article
• Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene  Academic Article
• Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis  Academic Article
• Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis  Academic Article
• Cost-effectiveness of alternative treatments for women with osteoporosis in Canada  Academic Article
• Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada  Academic Article
• Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada  Academic Article
• Current perspectives on benefits and risks of hormone replacement therapy  Conference Paper
• Current treatment options for osteoporosis.  Academic Article
• Deleting Rac1 improves vertebral bone quality and resistance to fracture in a murine ovariectomy model  Academic Article
• Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing  Academic Article
• Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis  Academic Article
• Denosumab: mechanism of action and clinical outcomes  Academic Article
• Determinants of health-related quality of life in women with vertebral fractures  Academic Article
• Development and pilot testing of a decision aid for postmenopausal women with osteoporosis  Academic Article
• Diagnostic criteria for osteoporosis should be expanded  Academic Article
• Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study  Academic Article
• Domains of Health-Related QUALITY OF LIFE in Elderly Women With OSTEOPOROSIS  Academic Article
• Drug Insight: choosing a drug treatment strategy for women with osteoporosis—an evidence-based clinical perspective  Academic Article
• Drug-Related Adverse Events of Osteoporosis Therapy  Academic Article
• Dual-Energy X-Ray Absorptiometry Technical Issues: The 2007 ISCD Official Positions  Academic Article
• Early Effects of Raloxifene on Clinical Vertebral Fractures at 12 Months in Postmenopausal Women With Osteoporosis  Academic Article
• Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate  Academic Article
• Effect of 12 Months of Whole-Body Vibration Therapy on Bone Density and Structure in Postmenopausal Women  Academic Article
• Effect of Whole-Body Vibration on Calcaneal Quantitative Ultrasound Measurements in Postmenopausal Women: A Randomized Controlled Trial  Academic Article
• Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)  Academic Article
• Effect of whole-body vibration on BMD: a systematic review and meta-analysis  Academic Article
• Effectiveness and safety of vitamin D in relation to bone health.  Academic Article
• Effects of Raloxifene on Fracture Severity in Postmenopausal Women with Osteoporosis: Results from the MORE Study  Academic Article
• Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study  Academic Article
• Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease  Conference Paper
• Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial  Academic Article
• Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures  Academic Article
• Efficacy of risedronate on clinical vertebral fractures within six months  Academic Article
• Empirically Based Composite Fracture Prediction Model From the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW)  Academic Article
• Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women  Academic Article
• Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis  Academic Article
• Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization.  Academic Article
• Etidronate for treating and preventing postmenopausal osteoporosis  Academic Article
• Etidronate for treating and preventing postmenopausal osteoporosis  Academic Article
• Etridronate therapy in the treatment and prevention of osteoporosis.  Academic Article
• Evaluation of easily measured risk factors in the prediction of osteoporotic fractures  Academic Article
• Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)  Academic Article
• Fluoride for the Treatment of Postmenopausal Osteoporotic Fractures: A Meta-Analysis  Academic Article
• Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study  Academic Article
• Frailty Change and Major Osteoporotic Fracture in the Elderly: Data from the Global Longitudinal Study of Osteoporosis in Women 3-Year Hamilton Cohort  Academic Article
• Frailty and Fracture, Disability, and Falls: A Multiple Country Study From the Global Longitudinal Study of Osteoporosis in Women  Academic Article
• Fruit and vegetable intake and bone health in women aged 45 years and over: a systematic review  Academic Article
• Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years  Academic Article
• Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study  Academic Article
• Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis  Academic Article
• Health-Related Quality of Life and Participation in Osteoporosis Clinical Trials  Academic Article
• Hormonal replacement therapy in breast cancer  Academic Article
• Hormone replacement therapy improves distal radius bone structure by endocortical mineral deposition  Academic Article
• Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?  Academic Article
• II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women  Academic Article
• III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis  Academic Article
• IV. Meta-Analysis of Raloxifene for the Prevention and Treatment of Postmenopausal Osteoporosis  Academic Article
• IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis  Academic Article
• Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data  Academic Article
• Image-Based Assessment of Spinal Trabecular Bone Structure from High-Resolution CT Images  Academic Article
• Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis  Academic Article
• Increasing calcium intake in young women through gain-framed, targeted messages: A randomised controlled trial  Academic Article
• Influence of bone densitometry results on the treatment of osteoporosis.  Academic Article
• International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study  Academic Article
• Intrarater Reliability of Dual-Energy X-Ray Absorptiometry–Based Measures of Vertebral Height in Postmenopausal Women  Academic Article
• Introduction  Academic Article
• Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis  Academic Article
• Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study  Academic Article
• Management of corticosteroid-induced osteoporosis  Academic Article
• Managing the Burden of Osteoporosis: Is There a Standard of Care?  Academic Article
• Measuring Quality of Life in Women with Osteoporosis  Academic Article
• Meta-Analyses of Therapies for Postmenopausal Osteoporosis  Academic Article
• Monitoring bone strontium intake in osteoporotic females self-supplementing with strontium citrate with a novel in-vivo X-ray fluorescence based diagnostic tool  Academic Article
• Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)  Academic Article
• Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW  Academic Article
• Obesity, Health-Care Utilization, and Health-Related Quality of Life After Fracture in Postmenopausal Women: Global Longitudinal Study of Osteoporosis in Women (GLOW)  Academic Article
• Optimizing care in osteoporosis: The Canadian quality circle project  Academic Article
• Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage  Academic Article
• Osteoporosis quality indicators using healthcare utilization data  Academic Article
• Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27  Academic Article
• Osteoporosis workup: evaluating bone loss and risk of fractures.  Academic Article
• Ostéoporose pendant la ménopause  Academic Article
• Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women.  Academic Article
• Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study  Academic Article
• Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study  Academic Article
• Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program  Academic Article
• Population screening for fracture risk in postmenopausal women — a logical step in reducing the osteoporotic fracture burden?  Academic Article
• Postmenopausal Osteoporosis  Academic Article
• Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy  Academic Article
• RETIRED: Osteoporosis in Menopause  Academic Article
• Rational use of oral bisphosphonates for the treatment of osteoporosis  Academic Article
• Rationale and design of MUSIC OS-EU: an international observational study of the treatment of postmenopausal women for osteoporosis in Europe and Canada.  Academic Article
• Recommendations for bone mineral density reporting in Canada.  Academic Article
• Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women  Academic Article
• Relationship Between Changes in Bone Mineral Density and Vertebral Fracture Risk Associated With Risedronate  Academic Article
• Resolution of Osteonecrosis of the Jaw After Teriparatide [Recombinant Human PTH-(1-34)] Therapy  Academic Article
• Resource utilization in postmenopausal osteoporosis without incident fractures.  Academic Article
• Responsiveness of endpoints in osteoporosis clinical trials--an update.  Academic Article
• Risedronate for the prevention and treatment of postmenopausal osteoporosis  Academic Article
• Risedronate for the prevention and treatment of postmenopausal osteoporosis.  Academic Article
• Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)  Academic Article
• Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos)  Academic Article
• Risk factors for low bone mass in healthy 40–60 year old women: A systematic review of the literature  Academic Article
• Romosozumab Treatment in Postmenopausal Women with Osteoporosis  Academic Article
• Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis  Academic Article
• Self-perception of fracture risk: what can it tell us?  Academic Article
• Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial  Academic Article
• Similar Proportions of Women Lose Bone Mineral Density With Raloxifene or Alendronate Treatment  Academic Article
• Strontium ranelate for preventing and treating postmenopausal osteoporosis  Academic Article
• Strontium ranelate for preventing and treating postmenopausal osteoporosis  Academic Article
• Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures  Academic Article
• Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study  Academic Article
• The 2002 Canadian bone densitometry recommendations: take-home messages.  Academic Article
• The Canadian Score™ Questionnaire  Academic Article
• The Decision to Accept Treatment for Osteoporosis Following Hip Fracture: Exploring the Woman’s Perspective Using a Stage-of-Change Model  Academic Article
• The Efficacy and Tolerability of Risedronate Once a week for the Treatment of Postmenopausal Osteoporosis  Academic Article
• The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design  Academic Article
• The Impact of Fragility Fracture on Health-Related Quality of Life  Academic Article
• The International Classification of Functioning, Disability and Health (ICF) Core Sets: Application to a postmenopausal woman with rheumatoid arthritis and osteoporosis of the spine  Academic Article
• The SOGC Statement on the WHI Report On Estrogen and Progestin Use in Postmenopausal Women  Academic Article
• The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review  Academic Article
• The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos)  Academic Article
• The effect of exercise on pQCT parameters of bone structure and strength in postmenopausal women—a systematic review and meta-analysis of randomized controlled trials  Academic Article
• The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: a retrospective analysis from the Canadian multicentre osteoporosis study  Academic Article
• The gastrointestinal tolerability and safety of oral bisphosphonates  Academic Article
• The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study  Academic Article
• The magnitude of an association between periodontal attachment loss and osteoporosis or osteopenia is small  Academic Article
• The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women  Academic Article
• The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives  Academic Article
• Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial  Academic Article
• Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers?  Academic Article
• Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians  Academic Article
• Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 3: Prevention of osteoporosis and CV effects of estrogens and antiestrogens.  Conference Paper
• Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk  Academic Article
• Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis  Academic Article
• Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study  Academic Article
• Utilização de recursos e custos em osteoporose  Academic Article
• V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women  Academic Article
• VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis  Academic Article
• VII. Meta-Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis  Academic Article
• VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women  Academic Article
• Vertebral fracture prevalence in a referral population of 750 Canadian men and women  Academic Article
• Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data  Academic Article
• What Predicts Early Fracture or Bone Loss on Bisphosphonate Therapy?  Academic Article
• When, Where and How Osteoporosis-Associated Fractures Occur: An Analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)  Academic Article
• Women's decisions about hormone replacement therapy after education and bone densitometry.  Academic Article